Related Experiment Video
Updated: Jul 4, 2026
09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Warfarin and intracranial haemorrhage
Rebecca Appelboam1, Elfyn O Thomas
1Anaesthesia and Intensive Care Medicine, Royal Devon and Exeter Hospital, Barrack Road, Exeter, Devon, UK. appelboamr@doctors.org.uk
Blood Reviews
|June 28, 2008
Summary
Warfarin therapy increases the risk and mortality of intracerebral hemorrhage. This review covers warfarin-associated intracranial hemorrhage, focusing on management, reversal, and re-anticoagulation strategies.
Area of Science:
- Neurology
- Hematology
- Pharmacology
Background:
- Long-term anticoagulation with warfarin is crucial for preventing thromboembolic events.
- Spontaneous intracerebral hemorrhage (ICH) is a serious complication of anticoagulation.
- Warfarin use is associated with an increased risk and mortality of ICH.
Purpose of the Study:
- To review the incidence, pathogenesis, and outcomes of warfarin-associated ICH.
- To evaluate optimal management strategies for these patients.
- To summarize current guidelines and provide practice points.
Main Methods:
- Literature review of studies on warfarin-associated ICH.
- Analysis of evidence regarding coagulopathy reversal.
- Evaluation of neurocritical care and surgical interventions.
- Review of re-anticoagulation strategies and prosthetic heart valve management.
Main Results:
- Warfarin significantly elevates the risk of ICH and associated mortality.
- Effective management involves timely reversal of anticoagulation.
- Neurocritical care and surgical options play a role in patient outcomes.
- Re-anticoagulation decisions require careful risk-benefit assessment.
Conclusions:
- Warfarin-associated ICH is a critical complication requiring specific management protocols.
- Optimal care involves prompt reversal, appropriate neurocritical care, and judicious re-anticoagulation.
- Adherence to guidelines and individualized patient care are essential for improving outcomes.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.